salvin has been researched along with verapamil in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andotra, SS; Khan, IA; Koul, S; Kumar, A; Qazi, GN; Raja, AF; Reddy, MV; Sangwan, PL; Thota, N | 1 |
Kalia, NP; Khan, IA; Koul, JL; Koul, S; Kumar, A; Qazi, GN; Reddy, MV; Sangwan, PL; Thota, N | 1 |
Connelly, M; Fatima, I; Gautam, LN; González, MA; Ling, T; Miranda-Carboni, G; Rivas, F; Tran, M; Wood, RK | 1 |
3 other study(ies) available for salvin and verapamil
Article | Year |
---|---|
Citral derived amides as potent bacterial NorA efflux pump inhibitors.
Topics: Amides; Bacterial Proteins; Ciprofloxacin; Molecular Structure; Multidrug Resistance-Associated Proteins; Staphylococcus aureus; Structure-Activity Relationship | 2008 |
Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors.
Topics: Alkaloids; Anti-Bacterial Agents; Bacterial Proteins; Benzodioxoles; Ciprofloxacin; Enzyme Inhibitors; Ethidium; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Nucleic Acid Synthesis Inhibitors; Piperidines; Polyunsaturated Alkamides; Staphylococcus aureus | 2008 |
(+)-Dehydroabietylamine derivatives target triple-negative breast cancer.
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Apoptosis; Biological Products; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Female; Humans; MCF-7 Cells; Molecular Structure; Stereoisomerism; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2015 |